Dignitana AB, world leader in scalp cooling innovation, announced today that the Company has signed a master contract with Hartford HealthCare in the U.S. to provide DigniCap Delta® at up to seven locations in Connecticut. The FDA-cleared DigniCap® Scalp Cooling System minimizes hair loss from chemotherapy in patients with solid tumors.
St. Vincent's Medical Center in Bridgeport, Connecticut will be the first location in the group to implement DigniCap later this month.
“Hartford HealthCare is a recognized leader in clinical excellence and healthcare innovation,” said William Cronin, Chief Executive Officer of Dignitana AB. “We are honored to welcome them to the growing list of providers selecting DigniCap so patients can maintain privacy, identity and control during cancer treatment.”
Hartford HealthCare is a large regional healthcare system with seven hospitals and more than 350 locations in Connecticut and Rhode Island. With a strong, unified culture of accountability and innovation, The Hartford HealthCare Cancer Institute offers a single, high standard of care treating over 6,000 new cancer cases each year.
The DigniCap Scalp Cooling System is available at over 160 locations in 30 states in the U.S. and in 38 markets globally.